Lindsey Allen | Head of Investor Relations and Communications |
Justin Klee | Co-Chief Executive Officer |
Margaret Olinger | Chief Commercial Officer |
James Frates | Chief Financial Officer |
Josh Cohen | Co-Chief Executive Officer |
Corinne Jenkins | Goldman Sachs |
Michael DiFiore | Evercore Inc. |
Marc Goodman | SVB Securities |
Neena Bitritto-Garg | Citigroup Inc. |
Ananda Ghosh | H.C. Wainwright & Co. |
Good afternoon. My name is Chuck, and I will be your conference operator for today. At this time, I would like to welcome everyone to the Amylyx Pharmaceuticals Third Quarter 2022 Earnings Conference Call. All participants will be in a listen-only mode. After today’s presentation, there will be an opportunity to ask questions.